ATRC Stock Analysis: Buy, Sell, or Hold?

ATRC - AtriCure, Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$28.31
-0.22 (-0.77%) ▼
5d: -4.13%
30d: -10.01%
90d: -29.54%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 05, 2026

Get Alerted When ATRC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: ATRC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$16.32
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.14
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ATRC is currently trading at $28.31, which is considered oversold relative to its 30-day fair value range of $28.94 to $30.96. The stock's valuation (Forward PE: 84.4) is in line with its historical norms (90.0). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, ATRC is in a strong downtrend. Immediate support is located at $27.45, while resistance sits at $30.67.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $48.57 (+71.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $28.94 - $30.96
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 71.6% below Wall St target ($48.57)

Fair Price Analysis

30-Day Fair Range $28.94 - $30.96
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $27.45
Resistance Level $30.67
Current Trend Strong Downtrend
Technical data as of Apr 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 84.43
Wall Street Target $48.57 (+71.6%)
Revenue Growth (YoY) 13.1%
Profit Margin -2.1%
Valuation Discount vs History -2.1% cheaper
PE vs Historical 84.4 vs 90.0 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -2.1% (market-implied from PE analysis)
1-Year Target $27.72 (-2%)
2-Year Target $27.13 (-4%)
3-Year Target $26.56 (-6%)
3-Yr Target (if PE normalizes) (PE: 84→90) $28.32 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 84.4, Growth: 166.7%) $95.55 (+238%)
Base: (SPY PE: 22.4, Growth: 166.7%) $25.29 (-11%)
Bear: (PE: 19.0, Growth: 166.7%) $21.50 (-24%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 84.4 to 90.0
Stabilization Target: $30.18 (+6.6%)
PE Expansion Potential: +6.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 02, 2026 7:56 AM ET
Data refreshes hourly during market hours. Next update: 8:56 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Vinayak Doraiswamy SELL 5000 shares 2026-03-12
Justin J Noznesky SELL 5166 shares 2025-11-26
Sven Wehrwein SELL 4967 shares 2025-11-25

Unlock Insider Activity

See real-time buying/selling by company executives for ATRC.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$607 61 BUY
ALC
Alcon AG
STRONG BUY
27 analysts
$94 59 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$186 58 HOLD
RMD
ResMed Inc
BUY
19 analysts
$297 61 BUY
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$318 62 BUY

More Analysis for ATRC

ATRC Technical Chart ATRC Price Prediction ATRC Earnings Date ATRC Investment Advisor ATRC Fair Price Analyzer ATRC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals